BioCentury
ARTICLE | Company News

Amarillo receives Orphan Drug designation

August 22, 2000 7:00 AM UTC

The FDA granted Orphan Drug designation for AMAR's Veldona oral low dose interferon-alpha to treat papillomavirus warts in the oral cavity of HIV positive patients. In February, the FDA granted Orphan...